Sunday, January 26, 2014

New Rules for Kidney Allocations in 2014

Allocating Kidneys

From SFGate, San Francisco, CA, by Victoria Colliver


When it comes to kidney transplants, it will soon no longer be first come, first served.

New rules, which go into place this year, will change the way kidneys from deceased donors are allocated across the country and hopefully balance out wait times for those who need one and improve their long-term survival.

Currently, a young kidney might go to someone with a very short life expectancy. If a kidney is found for someone who has antibodies that make finding a match extremely difficult, it may not matter. Someone else higher on the list will get the kidney, even someone without those complicating factors.

Someone in need of a transplant may get a kidney sooner or later, depending on the region where the patient lives.

"Right now it's just a hodgepodge," said Dr. William Bry, surgical director of the kidney transplant program at California Pacific Medical Center in San Francisco. "There's nothing to prevent a perfect kidney from a 16-year-old from going into a 78-year-old person with diabetes and heart disease."

Available kidneys for transplant are scarce, but the current rules put too much emphasis on the amount of time a patient has spent on the waiting list, said Bry, who served on a committee that helped develop the new criteria.

"There's certainly an ethical argument for the person waiting the longest to have their shot next," he said. "But in terms of limited resource, it makes more sense to get as many years out of that limited resource that we can."
Thousands waiting

More than 96,000 people in the United States are waiting for kidney transplants, and about 10 percent of them are expected to die as they wait.

The region that includes the Bay Area has among the longest wait times for kidneys in the United States - five to seven years, according to the California transplant Donor Network, which manages organ and tissue donation in Northern California - excluding the Sacramento area - and parts of Nevada. Regions diverse in race and ethnicities tend to have longer wait times.

It's been a decade since the federal government directed the United Network for Organ Sharing, the agency that oversees the transplant network nationwide, to make the changes.

Certain factors make kidney donation and transplantation different from that of any other organ. For example, dialysis, an artificial process that replaces some kidney functions such as waste removal and fluid removal, has been available to kidney patients for decades.

"So the sense of urgency was never there," Bry said. "Dialysis may not be a great option, but it can keep you alive."
The donors

A kidney transplant patient can also receive an organ from a living donor if they're fortunate enough to have a match. Unlike most other transplantable organs, people have two kidneys and can get by on one.

Still, the vast majority of transplanted kidneys come from deceased organ donors, and there just aren't enough to go around.

"We're trying to make a system that does not alter the priority people already have, but provides better benefit for the people who need it most," said Joel Newman, spokesman for the United Network for Organ Sharing.

One the bigger changes involves better matching the life expectancies of patients with the age and quality of the donated kidney.

Kidneys will still be available to older patients, but the change is designed to give younger patients the organs that are expected to last the longest. [Read more]



Fighting PKD

From Ionia Sentinel-Standard, Lake Odessa, Michigan, by Mattie Cook

Lake Odessa man fights kidney disease

Cris Male, a welder and father of four, suffers from polycystic kidney disease (PKD), a condition which requires him to spend nine hours each week undergoing dialysis.

Although Male was born with this condition, it did not begin affecting him until his early 50s.
Male's mother, as well as three of his four siblings, have been affected by PKD. His mother and twin brothers Carl and Curt have received kidney transplants, whereas Cris and his sister Dorean are on a waiting list.
"It's something I was born with, but I'm glad it waited until I was in my 50s to start affecting me," Male said.
Male, along with his wife Julie, inherited land and a home in Lake Odessa from her family. After living in North Carolina for nearly a decade, the couple decided to move back to the Lakewood area and start a family.
After years of unsuccessfully trying to have a baby, the Males decided it was time to become foster parents.
"We have a big house and we needed some kids to fill it up. We had two dogs, but we wanted the kids, too," said Male.
The couple fostered twins Austin and Adam for a year before adopting the then-six-year-old boys. A few years later, the couple adopted their son Malachi, who was just two days old at the time. Malachi's biological sister Gracie has also been adopted by the Males.
"We got Gracie when she was just five days old. Malachi and Gracie have the same mom, and she wanted Gracie and Malachi to be together," said Julie Male.
With four kids, two dogs and a home to take care of, Julie Male quit her job as a bus driver for Lakewood Area Schools and began focusing on taking care of her family. Cris Male has worked as a full-time welder for Bradford White in Middleville for 16 years.
"Bradford White understands and they're really supportive of everything I need to do," said Cris Male.
Cris Male works everyday, but on Mondays, Wednesdays and Fridays, leaves work early to receive dialysis at DaVita in Ionia.
"Cris Male goes about his normal routine every day; an incredible challenge given that he works full-time and goes to dialysis treatment three times a week for three hours - essentially, a part-time job to stay alive," said DaVita Communications member Justin Forbis.
After three years of receiving dialysis treatment, Cris Male does not let his situation change his positive outlook on life. [Read more]



Kidney Transplants

From DNAIndia.com, by Santosh Andhale

Mumbai all set for India's biggest domino kidney transplants

Saturday's medical exercise will involve 12 patients, 12 urologists, 6 vascular surgeons, 24 assistant surgeons, 5 nephrologists, 6 assistant nephrologists, 12 anaesthetists, 24 nursing staff, and 12 OTs.

The nation’s biggest domino kidney transplants will take place in the city on Saturday.
Six people will donate a kidney each to six others. Neither the donors nor the recipients are related to each other. The state government authorisation committee gave the final nod for the serial surgeries on Thursday.

The biggest domino transplants, involving 30 pairs, were done in the US.

The last domino transplants consisting of five donors and five recipients were held on June 25, 2013, in Mumbai. Saturday’s transplants will be carried out across Bombay, Hiranandani and Hinduja hospitals. The medical exercise will involve 12 urologists, six vascular surgeons, 24 assistant surgeons, five nephrologists, six assistant nephrologists, 12 anaesthetists, 24 nursing staff, and 12 operation theatres.

For a transplant, it is necessary that blood and tissue of a donor and recipient match. When they don’t, the domino procedure is followed — the donor of one pair donates a kidney to the recipient of another pair (they are unrelated to each other). The transplant is then carried out in a series till the last donor in the chain donates to the first recipient in the lineup. Legal issues are involved in organ donation cases when the donor and recipient are not related to each other.

Dr Vishwanath Billa, nephrologist, Bombay Hospital, and coordinator of Saturday’s domino transplants, tolddna on Thursday: “The success of the earlier procedure has set a precedent. It encourages people to opt for it as it reduces a patient’s waiting time for the organ. We are thankful to the state government for speeding up the process. We have got all legal permissions from the government.”

For a transplant, the blood and tissue of a donor and recipient must match. In the case of one of the recipients, Manish Yashwantrao, his father was ready to donate a kidney but there was a mismatch in blood group. Manish’s blood group is O, his father’s A. Doctors advised Manish to register with the Apex Swap Transplant Registry (ASTRA), which addresses the issue of mismatch in blood groups or tissue among those who come for a transplant. [Read more]



Dialysis Issues

From MedicalXpress.com

Sickle cell trait in African-American dialysis patients affects dosing of anemia drugs

The presence of sickle cell trait among African Americans may help explain why those on dialysis require higher doses of an anemia medication than patients of other ethnicities, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). Additional studies are needed to determine the long-term health consequences of this increased dosing.

Sickle cell trait represents the carrier state of sickle cell disease and is present in roughly 6% to 8% of African Americans. In sickle cell disease, individuals have two copies of a genetic mutation that produces an abnormal change in hemoglobin, the primary molecule that carries oxygen in the blood. This change can lead to severe anemia and abnormally shaped red blood cells that can block the flow of blood, causing organ damage. Generally, sickle cell trait (when only one copy of the mutation is present) is thought to be benign, but kidney abnormalities have been reported in some affected individuals.

Studies have also shown that African Americans with kidney failure require higher doses of medications to treat anemia during dialysis. Could the presence of sickle cell trait among African Americans play a role?

To investigate, Vimal Derebail, MD, MPH (University of North Carolina at Chapel Hill / UNC Kidney Center) and his colleagues examined laboratory and clinical data over six months in 2011 concerning 5319 adult African-American hemodialysis patients.

Patients with sickle cell trait received about 13% more of the medications used to treat anemia than other patients to reach the same level of hemoglobin. The investigators also found that sickle cell trait was slightly more common among dialysis patients, present in 10% of study participants compared with 6.5% to 8.7% in the general African-American population.

The findings suggest that the presence of sickle cell trait may explain, at least in part, prior observations of greater doses of anemia medications administered to African-American dialysis patients relative to Caucasian patients. [Read more]



From ABC27.com, Harrisburg, PA by Al Gnoza

Woman in danger of missing dialysis treatments

A Susquehanna Township woman says changes in the federal health care law are making it very difficult for her to get life-saving treatments.

DeAna Cornelius is suffering from renal failure and is waiting for a kidney transplant. In the meantime, she has been going for dialysis treatments three times a week.

Problems with her legs have made it difficult for DeAna to walk. That along with the fact that she weighs 500 pounds makes it necessary for DeAna to be taken by an ambulance and EMS workers to her dialysis.

But because of changes in the health care law, her insurance company has stopped paying for the ambulance. DeAna can't afford it out-of-pocket.

"They really help me," she said. "I just can't do it by myself."

"I spoke to the nurse," she said. "She had concerns about me falling and she didn't say not come. She just strongly recommended that I didn't try to come on my own."

DeAna has considered using CAT's Share a Ride, but she says the ride schedule would make for a 13-hour day. In the meantime, she is left to hope the insurance company grants her appeal and reverses its decision.

"I'm going to still fight," she said. "I have my bad days. I have my bad days and I want to give up. But I can't do that and I'm going to fight."



From TheTelegram, St. John, Nova Scotia, Canada, Transcontinental Media


Former Bonavista resident Tammy Fry has been unable to get home from St. John’s to spend Christmas with her family for two years. She says the burden of being away from a dialysis unit for several days is not worth the effort.

Fry was in her late 20s when she became very ill in May, 1998. She was taken to Grace General Hospital in St. John’s and began dialysis the same day.

At the time, Clarenville did not have a dialysis unit and she spent six weeks on hemodialysis before insisting on doing home (peritoneal) dialysis because she did not want to leave her friends, family and job to move to St. John’s.

She had a tube placed in her stomach for hemodialysis; and the process required a lot of equipment, requiring a lot of storage. She luckily had space at her parent’s place to hold the equipment.

She was doing peritoneal dialysis, a treatment for patients with severe chronic kidney disease, four times a day.

“I eventually had to do it in the middle of the night. I had a close friend who would stay with me and she would set her alarm and hook me up to my fluid in the middle of the night while I was still sleeping,” says Fry.

Then she acquired a machine to do it automatically at night. Soon after that, she travelled to Halifax for a kidney transplant. After coming home, her doctor told her she had only 40 percent kidney function, even after the transplant. They said she would be lucky if she got six months out of the kidney.

“I was always on pins and needles wondering when I would have to start dialysis again, and because I got so ill at the end of doing peritoneal dialysis before, I figured for sure I was going to end up being in St. John’s,” she says.

Fry began trying to wrap her head around the option of moving to St. John’s. She had been working at a pharmacy in Bonavista. Her doctor at the time recommended she change careers because the long hours of standing were not good for her.

“Because of my situation I was always retaining fluid from standing on my legs. The doctor said to go back and get retrained and get a desk job,” says Fry.

Following her transplant, she continued to work for six months as a pharmacist before leaving in May, 2000, to move to St. John’s to go back to school to train for office administration. Following the two-year program she got a job in St. John’s.

Her kidney transplant, which doctors predicted would only last her six months, ended up lasting 8 1/2 years.

Then, in September, 2007, she had to start dialysis again.

Though it’s been more than a decade since she moved to St. John’s, Fry still thinks about how her life would have been had she not had to relocate. [Read more]



From ABC.net, Australia, by Caroline Winter

Permanent dialysis pledged for APY Lands

As the incidence of chronic kidney disease in remote Indigenous areas continues to rise, so too do the number of families being torn apart. Many patients in South Australia's north have to leave home permanently, to get renal dialysis in larger cities and towns, but the State Opposition has unveiled an election promise to establish dialysis facilities in the most remote of communities. [Read more]

Tuesday, January 21, 2014

Improving PKD Diagnosing

Better PKD Detection

From Genomeweb.com by Molika Ashford

NGS Outperforms Current Sanger Method for Diagnosing Polycystic Kidney Disease in Cornell Study


Providing Kidneys

From the Wall Street Journal, by By GARY S. BECKER and JULIO J. ELIAS

Cash for Kidneys: The Case for a Market for Organs


In 2012, 95,000 American men, women and children were on the waiting list for new kidneys, the most commonly transplanted organ. Yet only about 16,500 kidney transplant operations were performed that year. Taking into account the number of people who die while waiting for a transplant, this implies an average wait of 4.5 years for a kidney transplant in the U.S.

The situation is far worse than it was just a decade ago, when nearly 54,000 people were on the waiting list, with an average wait of 2.9 years. For all the recent attention devoted to the health-care overhaul, the long and growing waiting times for tens of thousands of individuals who badly need organ transplants hasn't been addressed.

Finding a way to increase the supply of organs would reduce wait times and deaths, and it would greatly ease the suffering that many sick individuals now endure while they hope for a transplant. The most effective change, we believe, would be to provide compensation to people who give their organs—that is, we recommend establishing a market for organs.

Organ transplants are one of the extraordinary developments of modern science. They began in 1954 with a kidney transplant performed at Brigham & Women's hospital in Boston. But the practice only took off in the 1970s with the development of immunosuppressive drugs that could prevent the rejection of transplanted organs. Since then, the number of kidney and other organ transplants has grown rapidly, but not nearly as rapidly as the growth in the number of people with defective organs who need transplants. The result has been longer and longer delays to receive organs.

Many of those waiting for kidneys are on dialysis, and life expectancy while on dialysis isn't long. For example, people age 45 to 49 live, on average, eight additional years if they remain on dialysis, but they live an additional 23 years if they get a kidney transplant. That is why in 2012, almost 4,500 persons died while waiting for kidney transplants. Although some of those waiting would have died anyway, the great majority died because they were unable to replace their defective kidneys quickly enough.

The toll on those waiting for kidneys and on their families is enormous, from both greatly reduced life expectancy and the many hardships of being on dialysis. Most of those on dialysis cannot work, and the annual cost of dialysis averages about $80,000. The total cost over the average 4.5-year waiting period before receiving a kidney transplant is $350,000, which is much larger than the $150,000 cost of the transplant itself.

Individuals can live a normal life with only one kidney, so about 34% of all kidneys used in transplants come from live donors. The majority of transplant kidneys come from parents, children, siblings and other relatives of those who need transplants. The rest come from individuals who want to help those in need of transplants.

In recent years, kidney exchanges—in which pairs of living would-be donors and recipients who prove incompatible look for another pair or pairs of donors and recipients who would be compatible for transplants, cutting their wait time—have become more widespread. Although these exchanges have grown rapidly in the U.S. since 2005, they still account for only 9% of live donations and just 3% of all kidney donations, including after-death donations. The relatively minor role of exchanges in total donations isn't an accident, because exchanges are really a form of barter, and barter is always an inefficient way to arrange transactions.

Exhortations and other efforts to encourage more organ donations have failed to significantly close the large gap between supply and demand. For example, some countries use an implied consent approach, in which organs from cadavers are assumed to be available for transplant unless, before death, individuals indicate that they don't want their organs to be used. (The U.S. continues to use informed consent, requiring people to make an active declaration of their wish to donate.) In our own highly preliminary study of a few countries—Argentina, Austria, Brazil, Chile and Denmark—that have made the shift to implied consent from informed consent or vice versa, we found that the switch didn't lead to consistent changes in the number of transplant surgeries. [Read more]


Gift of Life

From 9News.com, NBC Affiliate Colorado, by AnneMarie Harper

Man is a walking billboard to find wife a kidney

DENVER- Think about what you would do if someone you loved needed a kidney or liver. Both of those organs can be donated while the donor is still alive, but finding living donors isn't easy.

Gary McCormack of Loveland has become a walking billboard to save his wife's life. Every day he wears a sweatshirt which says, "KIDNEY NEEDED Save a Live Please Call 970-667-7841."

Gary's wife of 52 years, Phyllis, is the one who needs the kidney. She has Polycystic kidney disease, which causes cysts to form in the kidneys. Eventually, they become enlarged and can rupture. PKD has killed nearly every member of Phyllis' family, including her mother, who was on dialysis for 20 years

Phyllis was diagnosed with PKD when she was 40 and has done everything she can to slow the progression.

"I have always exercised. I have always watched what I ate, kept my weight down," Phyllis said.

However, it wasn't enough and Phyllis is now in stage four kidney failure. When Phyllis gets to stage five, she, like her mother, will have to start dialysis. The only way to save her life is a kidney transplant.

According to the American Transplant Foundation, Phyllis is one of 2,400 Coloradans waiting for organ transplant. 2,300 of those people need a kidney or liver. Phyllis' doctors say the best option for her is a living donor.

Many people in Phyllis' situation ask a family member, but she can't. PKD is genetic, so her daughters can't donate. Gary has kidney stones and is diabetic. Phyllis needs what's called an altruistic donor: someone who doesn't even know her, but is willing to give her their kidney.

So, In addition to wearing his sweatshirt, Gary has written letters, which he sent to 95 churches, and made posters, which now hang all over town. A few people have called, but no one is a match.

The American Transplant Foundation says being a living donor is easier than you might think and it starts with a simple blood test . [Read more]



From wcsh6.com, Portland, Maine, by Vivien Leigh

Kidney transplant chain saves lives

OLD ORCHARD BEACH, Maine (NEWS CENTER) -- Gary Rutter suffers from polycystic liver disease. He had been receiving dialysis treatments several times a week for the past four years after both of his kidneys failed. He was registered in a program at Maine Medical Center that matches kidneys among groups of strangers.

On December 19th, Hallie Twomey of Auburn donated her kidney which was transported to Connecticut and transplanted into 20-year old Ryan Dasilva. One of Dasilva's father's kidneys was flown to a Toldeo Ohio hospital and transplanted into a 47-year old Michgan woman, another kidney from a 36-year old Michigan man was flown to Maine Medical Center and transplanted in Rutter -- all in the same day. Sutter says he is feeling great and is grateful to the program that saved his life.

The United Network of Organ Sharing program involved six patients, six kidneys and three hospitals. On December 19th, kidneys were removed from three different donors including Twomey, all were transplanted into waiting patients that same day including a Old Orchard Beach resident who had been on dialysis for nearly four years waiting for a new kidney. [Read more]



From SackvilleTribunePost.com, Canada, by Dr. Melissa Blake

A Nourishing Life – Organ donation definitely a worthy cause

My cousin was born with neuroblastoma, a rare type of childhood cancer that resulted in a surgery to remove one of her kidneys and radiation treatments. Several years later, as an adult, she was diagnosed with Polycystic Kidney Disease (PCKD). PCKD is generally a hereditary condition, although no one else in our family has it. The disease was progressing and Melanie was told she would soon require dialysis if a donor was not found.

Unfortunately, over 1,600 Canadians are added to organ wait lists every year and every year people on these lists die while waiting for a lifesaving organ.

In 2005, I was studying naturopathic medicine in Toronto (where my cousin’s specialists also happened to be). With things looking pretty desperate for a donor, I offered to donate my kidney to my cousin. In July of that year, after various tests to ensure we were a match and that I was healthy enough to be a donor, we underwent surgery to remove one of my kidneys, which was then put into my cousin – the wonders of modern medicine! After a very short hospital stay I was on my way home. Using my knowledge of naturopathic medicine, I recovered quickly, with very little pain and zero complications. Melanie’s hospital stay was longer as her body tried to reject the donated kidney. With the expertise of her doctors, they stabilized her immune system and she was able to go home with a new lease on life.

A transplant is a type of surgery where an organ or tissue is removed from one person, the donor, and given to another, the recipient. There are various reasons why a person may need a transplant including damage, trauma, or illness that influences the ability of that organ or tissue function.

The first transplant in the 1950s was of a heart valve. Since then, successful transplantations of almost all organs and tissues – including kidney, lung, liver, heart, bone marrow, pancreas, bowel, eye, and skin – occur every day. Major advancements in drug protocols have also drastically decreased rejection rates.

Not everyone has the opportunity or ability to be a live donor, and the need for organ and tissue donation far exceeds what live donors could provide. Also, not all organs can be donated from live donors. I feel blessed that I was given the chance to have the experience. I feel very proud of the choice I made and the impact it continues to have.

What everyone does have is the opportunity to save lives - in fact by making the commitment to donate your organs and tissues after you no longer need them, your decision can benefit more than 75 people and save up to eight lives! What a gift!

Anyone, regardless of age or medical history, can sign up to be a donor and there is no cost to do so.

According to the Canadian Transplant Society website, over 80 per cent of Canadians support organ transplant but less than 20 per cent have actually made plans to donate their organs and tissues.

If organ transplant sounds like a good idea to you, please take the appropriate steps to ensure someone else can benefit from your organs and tissues when you no longer need them. It can be hard to think about what’s going to happen to your body after you die but being an organ donor is a heroic, worthwhile decision that can save lives. Sign your donor card. Visit www.cantransplant.ca for provincial links to registration steps. Include your wishes in a will and let your friends and family know your intentions. Most provincial medicare renewal forms allow you to clearly indicate if you wish to donate.

My cousin’s story doesn’t end after a new kidney; she truly is making the most of her second chance at life. In July of this year, eight years after the transplant, she traveled to South Africa to compete for Team Canada in the World Transplant Games. To read more about my amazing cousin and her mission to bring awareness to organ donation, visit The Pear Tree’s Facebook page for a link to her story. [Read more]


Kidney Treatments

From The Wall Street Journal, by Laura Landro

Patients Can Do More to Control Chronic Conditions


By the time Gail Rae-Garwood was diagnosed with chronic kidney disease at age 60, it was already too late for prevention, and there is no cure. But Ms. Rae-Garwood decided she could do something else to preserve her quality of life: slow the progression of the disease.

For the millions of Americans over 50 who have already been diagnosed with chronic ailments like kidney disease, diabetes, heart disease, rheumatoid arthritis and chronic obstructive pulmonary disease, careful management can’t turn back the clock, but it can buy time. It takes adherence to medications, sticking to recommended diet and exercise plans, and getting regular checkups.

As simple as that sounds, experts say, patients often don’t hold up their end of the bargain, and doctors don’t always have the time to help between visits. Chronic ailments may also lead to depression, which itself is associated with poor adherence to medication across a range of chronic illness, according to a 2011 study in the Journal of General Internal Medicine.

“The whole goal in conditions that are lifelong, and aren’t going to go away, is to stabilize them and keep them as stable as possible for as long as possible,” says Edward Wagner, a researcher and founding director at Seattle-based Group Health Research Institute.

Dr. Wagner developed a protocol known as the chronic-care model in the 1990s, which has been increasingly adopted by many health-care providers. One of its primary goals, in addition to careful monitoring, is teaching patients self-management skills. “Evidence is mounting that the more engaged and activated patients are in their own care, the better the outcomes,” Dr. Wagner says.

Take kidney disease. One of the fastest-growing chronic conditions world-wide, it affects 26 million Americans, and millions of others are at increased risk, according to the National Kidney Foundation. Over time, the kidneys lose their ability to filter waste and excess fluid from the blood; the condition may be caused by diabetes, high blood pressure and other disorders. But patients may not have symptoms until it is fairly advanced. As dangerous levels of fluid and wastes build up in the body, it can progress to so-called end-stage renal disease, or kidney failure. Without artificial filtering, known as dialysis, or a kidney transplant, the disease can be quickly fatal.

But especially in earlier stages, lifestyle changes that ease the burden on the kidneys can have a marked effect, including eating less salt, drinking less alcohol and keeping blood pressure under control. Doctors may suggest a “renal diet” that includes limiting protein, phosphorous and potassium, because kidneys can lose the ability to filter such products.

Sometimes modest changes can make a difference. Even small amounts of activity such as walking 60 minutes a week might slow the progression of kidney disease, according to a study published last month in the Journal of the American Society of Nephrology.

There are plenty of resources to help kidney patients manage their disease, including the kidney foundation website (kidney.org) and classes offered by the dialysis division of DaVita HealthCare Partners Inc. The company says it educates about 10,000 patients annually at free “Kidney Smart” classes across the country.

Ms. Rae-Garwood says she decided to become engaged in her own care and share what she learned with fellow patients, after she was diagnosed in 2008 with Stage 3 kidney disease.

“People need to be educated and learn how to manage it so that they are not immediately on dialysis or on death’s door,” she says. [Read more]

Sunday, January 12, 2014

Kidney Dialysis Superheros

Life With Kidney and Dialysis Treatments

From Washington Post, by John Kelly, Columnist

Blood brothers: Hyattsville teen wants to create kidney dialysis superheroes

In his imagination, Elmer Reyes wears a cape, possesses super strength and can fly. In his imagination, Elmer is a superhero.

Elmer describes his alter ego to me as he sits in a large, padded chair at Children’s National hospital. Two tubes snake from his arm. One removes blood from his body. The other returns it, freshly purified.

“It does what a kidney usually does,” Elmer explains of the machine whirring by his side, “which is clean out my blood and filter it.”

Elmer is 18. He has kidney disease, and for pretty much his entire life, he has come here for hemodialysis three times a week, 21 / 2hours each time.

That’s given him a lot of time to kill. Usually he watches TV or listens to music. But lately Elmer has been thinking about creating a comic book about kids like him.

“The concept is: Patients in dialysis, what makes them strong and what makes them weak?” he says. “What if I made a comic strip that represents us?”

He calls it the Kidney Kids for Justice. [Read more]



From MoneyLife, Mumbai, India, by N MADHAVAN
Are you afraid of the cost of kidney treatment?

Kidney care is taught to patients and also made affordable by this organisation, says

A group of five young nephrologists from Mumbai met on the sidelines of the Indian Society of Nephrology Conference at Nagpur (India) in 2003. Having returned from Canada and Australia, they knew that a lot needs to be done in the dialysis sector in the city of Mumbai. The thought of starting a state-of-the-art stand-alone dialysis centre took shape during their conversations. There were lots of hurdles, but the main issue was ... [Read more]



From Sandzak News, Blog


Healthy kidneys сlеаn уουr blood bу removing excess fluid, minerals, аnd wastes. Thеу аlѕο mаkе hormones thаt keep уουr bones strong аnd уουr blood healthy. Whеn уουr kidneys fail, harmful wastes build up іn уουr body, уουr blood pressure mау rise, аnd уουr body mау retain excess fluid аnd nοt mаkе enough red blood cells. Whеn thіѕ happens, уου need treatment tο replace thе work οf уουr failed kidneys.

Dialysis іѕ thе process οf replacing renal function іn thе absence οf a working kidney. Nеіthеr hemodialysis nοr peritoneal dialysis itself іѕ painful.

Hοw Long Dο People Live οn Kidney Dialysis?

Those undergoing kidney dialysis treatment possess a very general, average life expectancy οf four years.

Indeed, thе cause οf thе kidney failure plays a hυgе role іn thе survival rate fοr those οn dialysis.

Polycystic kidney disease: 94 percent survival through year one, 70 percent through year five аnd 42% аftеr 10 years.

Glomerulonephritis: 88% survival through year one, 58 through year five аnd 37 percent аftеr 10 years.

Obstructive Nephropathy: 82% through year one, 46% through year five аnd 21 percent аftеr 10 years.

Unknown: Seventy-six percent through year one, forty-one percent through year five аnd nineteen percent аftеr ten years.

High Blood Pressure: 77% through year one, 33% through year five аnd 14 аftеr 10 years.

Diabetes: 71 percent through year one, 29% through year five аnd 11 percent аftеr 10 years.

Keep іn mind whеn уου аrе looking аt thеѕе numbers, thаt thеу аrе a blend οf аt lеаѕt two averages. Thе average life span οf dialyzors whο dο follow thеіr exercise, diet аnd treatment prescriptions, аnd thе average life span οf dialyzors whο dο nοt follow thеіr exercise, diet аnd treatment prescriptions.

A careful diet іѕ a very іmрοrtаnt раrt οf thіѕ treatment process tο prevent waste frοm building up dangerously іn thе body between dialysis treatments. If thе diet іѕ nοt properly maintained, a patient mау experience high blood potassium levels, fluid overload, weight loss, аnd bone disease, аmοng οthеr conditions. [Read more]



Gift of Life

From Ledger-enquirer.com, Columbus, GA, BY CHUCK WILLIAMS


PASADENA, Calif. -- What a difference three years can make.

Just ask Clay Taber.

Clay, his wife, Laura, and his parents, Allen and Sandra, are in sunny -- and warm -- California getting ready for today's BCS championship game between Auburn and Florida State in the Rose Bowl.

An Auburn graduate and season-ticket holder since he was 2 -- that is not a typo -- Taber is happy for many reasons, not the least of which is he is healthy again.

Clay was diagnosed in the fall of 2010 with Goodpasture's Syndrome, an autoimmune disorder characterized by kidney disease and lung hemorrhage. No exact cause is known for Goodpasture's disease, which makes the body's immune system fight normal tissues by creating antibodies that attack the lungs and kidneys.

On Jan. 10, 2012, Clay got the greatest of gifts, a kidney transplant that was needed due to this rare disease that was shutting down his kidneys. Emory University Hospital nurse Allison Batson contributed the organ.

So, what does all of this have to do with Auburn football? Plenty.

Clay became ill as Auburn was making a run to an unlikely national title. He spent much of the season in a hospital room and, at 23 years old, he missed his first Auburn home games since he was a toddler.

When Auburn reached the BCS title game in Glendale, Ariz., that year, Clay was stabilized and his parents made the decision to go. Clay's kidneys were in bad shape, and he was having dialysis three times a week. [Read more]



From UC San Diego Health Sources, CA,  News Release


Random stadium seat assignment leads to lifesaving transplant surgery

In October 2013, Louis Munoz donated one of his kidneys to William Lynch. The organ match would not have occurred without a bit of serendipity and a big love of football. Munoz and Lynch had been childhood friends, but hadn’t seen each other in years – then they found themselves randomly seated next to each other at a Chargers game.

“Louis and I knew each other as kids and then lost touch. Years later, by surprise, we ended up sitting right next to each other at Chargers games,” said William, a middle school teacher. “When I started missing games, Louis asked me why and I explained that due to kidney complications, I’d been unwell. His wife half-jokingly suggested that he give me a kidney.”

Louis immediately volunteered to be tested as a possible donor. William initially declined his friend’s offer, believing another donor would come through. But when that didn’t happen, Louis followed through and proved to be a match.

“I am so blessed that Louis has chosen to give me this new lease on life,” said William. “I can’t express to him how grateful I am. I promised Louis I will take care of this kidney the best that I can.” [Read more]

Read more here: http://www.ledger-enquirer.com/2014/01/05/2886494/kidney-transplant-enables-auburn.html#storylink=cpy


Read more here: http://www.ledger-enquirer.com/2014/01/05/2886494/kidney-transplant-enables-auburn.html#storylink=cpy



From The Bolton News, United Kingdom

Generous friend donates kidney to Hindley mum

A MUM-of-two has been granted a lifeline by a generous friend who has donated a kidney to her.

Helen Cavanagh, aged 51, selflessly offered to give up her kidney to herwork colleague Julie Rogers, who suffers from polycystic kidney disease and had to have both kidneys taken out in 2011.

Julie, who lives in Hindley, has been on dialysis three times a week since, and Helen was so shocked when she realised how ill her friend was that she offered her the ultimate gift of life.

Julie, aged 45, said: “We have worked together for a long time and when I had my kidney removed in November 2011, she was a great support. And then she just told me one day around Easter this year she wanted to be a donor for me.

“Before then we had never been really really close, so I was completely overwhelmed. I couldn’t believe it. I almost didn’t want to get too excited in case she changed her mind, because that does happen sometimes.

“But Helen just said she had already thought about it and she wanted to do it and be able to help in whatever way she could. I accepted the offer and we haven’t looked back since.”

Julie, mum to Sophie, aged 19, and Jordan, aged 22, works at RBS in Bolton. She started working with Helen, a project manager for RBS in Manchester, 16 years ago.


The operation, which went ahead on Friday, was a success and now both women are recovering well at Manchester Royal Infirmary. [Read more]



PKD and Kidney Fundraising

From Lancashire Telegraph, United Kingdom

Fun day to raise cash for Blackburn Mayor's appeal

BLACKBURN with Darwen mayor Salim Mulla’s family have arranged a fun day to raise funds for his official charity kidney care appeal.

The appeal aims to raise £50,000 for two dialysis machines for the Blackburn Royal Hospital as borough residents currently have to travel to Preston or Accrington for renal care.

Coun Mulla made raising cash for the machines his mayoral charity after his wife Sayeeda suffered kidney disease and needed dialysis while waiting six years for a transplant. He paid a visit to the hospital just before Christmas, chatting with patients and staff.

The fun day will be on February 16 at Audley Sports Centre on Chester Street.



From Daily Record and Sunday Mail, United Kingdom, By Alastair McNeill


Organiser Kirstine Cubis, of Arden Road, had been a dialysis patient for more than three years before she received a new kidney in May.

The plight of a Hamilton woman who underwent a kidney transplant six months ago has inspired more than £3500 in fundraising for a Lanarkshire kidney charity.

The money for Lanarkshire Kidney Patients’ Association was raised during a night at Hamilton’s Barleycorn pub which was attended by more than 150 people

Kirstine Cubis, of Arden Road, had been a dialysis patient for more than three years before she received a new kidney in May.

She and her sister Elaine Zanjani of High Earnock both suffer from polycystic kidney disease – a hereditary condition which claimed the life of their mother Joan.

Mrs Cubis had lived in Elgin Terrace with husband George until her death in the early 1990s aged 59.

Kirstine and Elaine’s brother Derek and sister Patricia fortunately do not carry the gene responsible for the condition.

Each of those attending the September fundraising night at the Barleycorn paid a £5 entry fee.

Cash was also raised through a tombola and a raffle with prizes which included a holiday in Dubai.

Forty-four-year-old Kirstine said: “I’m really touched that so many people took part. I’d like to thank everyone who supported me and a cause very close to my heart and my family’s hearts and help raise awareness of organ donation and the excellent work of the staff at the renal unit of Monklands Hospital. I’m really grateful.

“I’d especially like to thank Barleycorn managers Clare Paterson and Ann Laughlan for the use of the pub’s function room and their donation of food for the event.”

The sum of £492 also came from Jean Ward of Hamilton who ran the Great Scottish Run half marathon. Mrs Ward is the mum of Kirstine’s son Stephen’s girlfriend Nicole. And £250 came from relatives Neil and Mandy Teras of Hamilton who raised the money during Neil’s 40th birthday party.

Kirstine and Elaine were diagnosed with polycystic kidney disease after their mother’s diagnosis in the late 1980s.

Before her transplant, Kirstine had to attend three four-hour dialysis sessions every week.

She explained: “Every patient is different, but one of the symptoms of the disease for me was a constant tiredness. The treatment helped me cope with daily life.”

Sister Elaine is currently on the waiting list for a kidney transplant, and following her transplant Kirstine attends Monklands Hospital’s renal unit on a monthly basis.

The money donated to Lanarkshire Kidney Patients’ Association helped fund Christmas presents for kidney patients, an arts and crafts programme and a summer trip. [Read more]

Clinical Study Results for Novel Iron Replacement Drug Triferic(TM) Demonstrate Significant ESA Sparing and IV Iron Reduction While Maintaining Hemoglobin in CKD-HD Patients

WIXOM, MI, Jan 07, 2014 (Marketwired via COMTEX) -- Rockwell Medical, Inc. RMTI +3.71% , a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron replacement, secondary hyperparathyroidism and hemodialysis, announced today that its abstract "Triferic(TM) (Soluble Ferric Pyrophosphate) Administered via Dialysate Maintains Hemoglobin and Reduces ESA and IV Iron Requirements in CKD-HD" was selected as the best abstract submitted to the 34th Annual Dialysis Conference to be held in Atlanta, Georgia, February 8-11, 2014. The Company will be presented the Award by the President of the International Society for Hemodialysis during the Award Ceremony.

Rockwell's PRIME study was a nine-month, prospective, randomized, placebo-controlled, double-blinded, multi-center study in United States that randomized 108 patients equally to dialysate containing Triferic(TM) (iron) versus conventional dialysate. The objective of the study was for patients in both groups to maintain their Hgb between 9.5 - 11.5 g/dL for the duration while adhering to the same erythropoietin stimulating agent (ESA) and IV iron dosing criteria. The PRIME study successfully met its primary endpoint, demonstrating that regular administration of Triferic(TM) via dialysate reduced the usage of ESA a statistically significant 37.1% compared to placebo, while maintaining iron balance and maximizing iron delivery. Among the hypo-responsive patients in the study, those who do not respond well to ESA therapy, Triferic(TM) reduced ESA use by 74.4% compared to placebo, including a 9% reduction in baseline ESA in the Triferic(TM) group. Triferic(TM) also reduced IV iron requirements by 45% compared to placebo. The significant ESA sparing and IV iron reduction from Triferic(TM) was observed without an increase in serum ferritin or transferrin saturation, demonstrating that the Triferic(TM) (iron) being delivered to the patient was being utilized as intended and was not being trapped or stored. [Read more]



PKD and Kidney Disease Alternative Medicine Treatments

From OnlyMyHealth.com

Alternative Treatments for Kidney Disease

Consider Dandelion Roots and Leaves, Apple Cider Vinegar, Baking Soda, Garlic, Legumes and Sprouts [Read more]

Sunday, January 5, 2014

Study: Hemodialysis patients treated in for-profit centers have higher hospitalization rate

PKD  & Kidney Treatment


UPDATE: An earlier version of this article stated in the headline that hemodialysis patients treated in for-profit centers have higher mortality rates. The study actually only shows higher rates of hospitalization, not mortality.


Patients receiving hemodialysis in for-profit facilities had a 15% higher relative rate of hospitalization compared with those in nonprofit facilities, a study published online Dec. 26 in the Clinical Journal of the American Society of Nephrology found.

Researchers conducted a retrospective cohort study using the U.S. Renal Data System, including all adults aged 18–100 years old who started dialysis between Jan. 1, 2005 and June 30, 2008. Patients who died, received a kidney transplant, recovered kidney function, or were lost to follow-up in the first 90 days of dialysis were excluded. The cohort included 150,642 dialysis patients, of which 12,985 (9%) were receiving care in nonprofit dialysis facilities. In adjusted models, the study authors said they found patients receiving hemodialysis in for-profit facilities had a 15% higher relative rate of hospitalization compared with those in nonprofit dialysis facilities. Patients on hemodialysis receiving care in for-profit dialysis facilities had a 37% higher rate of hospitalization for heart failure or volume overload and a 15% higher rate of hospitalization for vascular access complications. Among patients receiving peritoneal dialysis, the rate of hospitalization in for-profit versus nonprofit facilities was not significantly different, according to the study.

(CMS takes a step back on tackling hospitalizations under the ESRD QIP)

"Proposed mechanisms by which profit status and organizational structure may be linked to adverse outcomes include differences in staffing, training level of staff, and specific differences in treatment or processes of care such as hemodialysis session length and medication dosing protocols," the authors wrote.

Baseline characteristics for adults on hemodialysis differed among those in for-profit compared with nonprofit dialysis facilities. The proportion of patients with hemodialysis catheters at the start of dialysis was higher in for-profit facilities. The prevalence of atherosclerotic heart disease, cerebrovascular accident or transient ischemic attack, cancer, pulmonary disease, and inability to ambulate or transfer was significantly higher in nonprofit facilities, the authors wrote. The proportion of patients with reported nephrology care before ESRD was higher in nonprofit facilities, and the distribution of patients by profit status differed by region. In adults on peritoneal dialysis, the prevalence of baseline chronic diseases was similar among patients in for-profit and nonprofit dialysis facilities.

"Amid the concerns about whether ESRD patient outcomes are affected by the profit status of dialysis providers, it is important to stress that not all for-profit providers are equal, and even if there is some relationship between outcomes and profit status, that characterization may not apply to all for-profit (or nonprofit, for that matter) organizations," Barry M. Straube, MD, said in an accompanying editorial. [Read more}


From PharmaBiz.com, News Release

EMA accepts Otsuka's MAA for tolvaptan to treat autosomal dominant polycystic kidney disease

The European Medicines Agency (EMA) has accepted marketing authorisation application (MAA) for the potential approval of Otsuka Pharmaceuticals' tolvaptan for treatment of autosomal dominant polycystic kidney disease (ADPKD). Phase III clinical trial results that form the basis of the regulatory filing were published in the New England Journal of Medicine.

“Otsuka is delighted that the EMA will review the tolvaptan MAA for the treatment of ADPKD, based on compelling data from our pivotal three-year Phase III clinical trial,” said Ole Vahlgren, CEO & president, Otsuka Europe. “If approved, tolvaptan will represent a breakthrough for patients with a disease for which there are currently no licensed treatments.”

Tolvaptan is a selective V2 vasopressin receptor antagonist that has been hypothesised to slow the progression of ADPKD by reducing the development and growth of kidney cysts.

ADPKD is a hereditary genetic disease characterised by the development of multiple, non-malignant cysts in the kidneys due to inherited or acquired genetic mutation(s). Cyst growth and expansion in both kidneys leads to slow deterioration of kidney function, and in approximately 50 per cent of patients, to end-stage renal disease (ESRD) and renal failure. ADPKD typically results in symptom manifestations (e.g. hypertension and kidney pain) in adulthood. Half of all ADPKD patients will require dialysis or transplantation by the age of 60 and people with ADPKD account for up to one in 10 people on maintenance dialysis. The condition is estimated to affect approximately 200,000 people in Europe.

The Committee for Medicinal Products for Human Use (CHMP), a committee within the EMA, is responsible for evaluating the application and will provide a recommendation on whether tolvaptan should receive marketing authorisation. The CHMP may request further information from the applicant before adopting an opinion. If the committee’s opinion is positive, it is forwarded to the European Commission to make the final decision.

In August 2013, the EMA’s Committee for Orphan Medicinal Products (COMP) granted tolvaptan orphan drug designation for the treatment of ADPKD. To qualify for orphan designation, the prevalence of the condition in the EU must not be more than five in 10,000. In addition, the new medicine must be of significant additional benefit to those affected by the condition, and no satisfactory method of diagnosis, prevention or treatment of the condition must exist.

In Japan, the application for ADPKD is currently under review. In the United States, Otsuka and FDA have been working together to determine the most appropriate path forward to allow tolvaptan to be available for patients suffering from ADPKD.


From YottaFire.com, Press Release

Testing technique could lengthen lifespan of dialysis patients

New approach spots deadly hormone imbalances in end-stage kidney disease patients

A new testing method can better detect potentially fatal hormone imbalances in patients with end-stage kidney disease, according to a recent study accepted for publication in The Endocrine Society’s Journal of Clinical Endocrinology & Metabolism (JCEM).

At the end of 2009, more than 871,000 Americans were being treated for end-stage renal disease, according to the National Institutes of Health’s National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). These patients require dialysis or kidney transplants to stay alive. About 10 to 20 percent of patients with chronic kidney disease stage 5, or end-stage renal disease, die each year.

One key factor that contributes to the risk of death in this population is levels of parathyroid hormone, the hormone that makes calcium available in the blood for important body functions. When parathyroid hormone levels are too low or too high, it raises the mortality risk for patients with end-stage renal disease.

“The current tests for parathyroid hormone levels overlook a key factor,” said the study’s lead author, Berthod Hocher, MD, PhD, of the University of Potsdam in Potsdam-Rehbrücke, Germany. “When parathyroid hormone interacts with oxygen under conditions of stress such as end-stage kidney disease, it becomes biologically inactive. Our new approach is the first to differentiate between non-oxidized, biologically active parathyroid hormone and oxidized parathyroid hormone. This will result in better monitoring and treatment for patients who have end-stage renal disease.”

Researchers conducted a prospective cohort study to test this approach. The study authors monitored a group of 340 dialysis patients over the course of a five-year period. Researchers tested blood samples from the patients to determine their parathyroid hormone levels. During the course of the follow-up period, 170 participants died, many from cardiovascular disease, infections or cancer.

The patients who survived had higher median levels of non-oxidized parathyroid hormone than the study participants who died. The study found an increased rate of survival among dialysis patients who had the highest levels of non-oxidized parathyroid hormone.

“With more precise parathyroid hormone testing, health care professionals will have the information they need to improve clinical outcomes,” Hocher said. “The nephrology community has long recognized there is an issue with current testing approaches, and now we can solve this problem and improve patient care.” [Read more]


From CourierMail, Brisbane, Australia, by JANELLE MILES

Teenager Bianca Scott faces lifetime of kidney dialysis without $500,000 a year drug Soliris

TEENAGER Bianca Scott faces a lifetime of kidney dialysis unless she can access a drug that costs the price of a house for only a year's treatment.

The Gold Coast 17-year-old was happy and healthy as she celebrated the end of her schooling a month ago, but within a week was fighting for her life in hospital with a rare kidney disease.

"It's been a nightmare," her mother Tammy Hamawi said. "We understand now, from our own point of view, how people's lives can change in an instant."

Her only child was first diagnosed with atypical haemolytic uraemic syndrome as a seven-month-old in New Zealand but recovered and has been relatively healthy since - until recent weeks.

The disease results in damage to the small blood vessels in the kidney and other organs, including the heart and brain, caused by a genetic abnormality affecting immune system proteins.

Bianca, whose uncle died from the condition at six years of age, is receiving a treatment, known as plasma exchange which removes and replaces the defective proteins, but the therapy has been ineffective in halting damage to her kidneys and she requires regular dialysis at the Gold Coast University Hospital.

She's been unable to access a drug, marketed as Soliris, which kidney specialist Nicole Isbel says has been effective in allowing similar patients to come off dialysis. [Read more]


From Azom.com

Clay Minerals from Ancient Volcanic Ash May Help Treat Chronic Kidney Disease

Clay has healing powers. This natural product is destined to help treat chronic kidney disease: a well-tolerated agent based on clay minerals lowers patients’ excessive phosphate levels.

Miss M. spends around 15 hours a week in hospital. Her renal functions are limited, and her kidneys are no longer able to filter toxins from her blood. She is a dialysis patient, forced to rely on this artificial blood purification treatment that, although essential, greatly impairs her quality of life. She has to make three trips a week to the dialysis clinic and going away for longer than a few days is almost out of the question. And Miss M. is no exception: In Germany alone, over six million people suffer from some form of chronic renal disease. Around 70,000 depend on dialysis and they are joined by some 15,000 new dialysis patients every year. Poor diet and an aging population are contributing to the dramatic rise in chronic renal disease worldwide, with high blood pressure and diabetes the most significant risk factors related to renal failure.

When suffering from renal failure, the body is unable to filter out phosphates in sufficient quantities, and the resulting excess is then absorbed into the blood. This causes a build-up of calcium-phosphate deposits in the blood vessels, which can over an extended period lead to arteriosclerotic heart disease and premature death. Compared to people with healthy kidneys, those with compromised renal function are at least ten times more likely to suffer a heart attack or stroke. To counteract this increased risk, people suffering from chronic renal insufficiency are required to take phosphate binders with meals. In the stomach and intestines, these medications bind to phosphates from food so that they can be excreted undigested instead of being absorbed into the blood. The problem is that existing medications, such as calcium and aluminum salts, cause serious side-effects including constipation, hypercalcemia (an elevated level of calcium in the blood), and neurologic disorders.

Gentle alternatives to pharmaceutical treatments

But hope is in sight for sufferers of chronic renal disease. Scientists from the Fraunhofer Institute for Cell Therapy and Immunology IZI in Rostock teamed up with FIM Biotech GmbH to develop an effective therapeutic agent that patients can tolerate well. Formed by marine deposits of volcanic ash 60 billion years ago, clay minerals found in the Friedland area of north-east Germany provide the basis for the new agent. The clay first has to be processed before being refined using a special technical process. [Read more]



PKD Fundraising

From PKD Foundation of Canada

December 2013 PKD e-News (Last chance to support our year-end campaign)

Support

There’s Still Two Days Left to Support Our Year-End Campaign

As 2013 draws to an end and we gather with those close to us to celebrate the holiday season, we here at the PKDFOC would like to express our heartfelt thanks to all of you, our donors, who have made 2013 our strongest year to date!

This year, we once again saw incredible growth in PKD awareness on a local and national level through our Chapter initiatives and volunteer-driven events in the community. Additionally, the Walk for PKD – our signature fundraising campaign – reached record-setting levels; bringing out 850+ people to walk for a cure, and raising more than $173,000!

With your help, we continued our support of the University Health Network’s Hereditary Kidney Disease Clinic by awarding a One-Year Translational Research Fellowship to Dr. Moumita Barua (Toronto General Hospital.) The funding of this Fellowship and the work done within this clinic couples clinical care with research, so that new knowledge for the benefit of PKD patients across Canada can be generated.

Our accomplishments over 2013 are inspiring and would not have been possible without your help. Looking ahead to 2014, we are excited to further fund leading Canadian research into a treatment and cure for PKD, but the amount of research we are able to support depends on the funds that are available.

Please make your tax-deductible gift today. Join us in the fight to END PKD.



PKD Knowledge

From MayoClinic.org, By Mayo Clinic Staff

Polycystic kidney disease: Definition

Polycystic kidney disease (PKD) is a disorder in which clusters of cysts develop primarily within your kidneys. Cysts are noncancerous round sacs containing water-like fluid.

Polycystic kidney disease isn't limited to your kidneys, although the kidneys usually are the most severely affected organs. The disease can cause cysts to develop in your liver and elsewhere in your body.

A common complication of polycystic kidney disease is high blood pressure. Kidney failure is another common problem for people with polycystic kidney disease.

Polycystic kidney disease varies greatly in its severity, and some complications are preventable. Lifestyle changes and medical treatments may help reduce damage to your kidneys from complications, such as high blood pressure.



Kidney News

From RenalAndUrologyNews.com, by Jody A. Charnow


Mortality rates in end-stage renal disease (ESRD) and dialysis populations are declining but remain much higher than in the general population, according to the 2013 Annual Data Report from the U.S. Renal Data System (USRDS).

The adjusted mortality rate among ESRD patients (per 1,000 patient years at risk) decreased from 351 in 1996 to 241 in 2011, a decline of 31.3%. During that same period, the adjusted mortality rate in the dialysis population dropped from 362 to 266, a decrease of 26.5%.

In 2011, among individuals aged 65 years or older, the adjusted mortality rate was 272.5 and 314.3 per 1,000 patient years at risk in the ESRD and dialysis populations, respectively, compared with 48 in the general population.

The adjusted first-year all-cause mortality rate from day 1 in 2010 was 254.4 per 1,000 patient years at risk, 268.8 for hemodialysis (HD) patients, 121.4 for peritoneal dialysis (PD) patients, and 54.4 for kidney transplant patients (from the date of transplant). From day 90, the rate was 221.5 for HD patients and 126 for PD patients. [Read more]
Genetic factors in African Americans with chronic kidney disease (CKD) put them at a greater risk for end-stage renal disease (ESRD) compared to white Americans, according to a new study released in the New England Journal of Medicine. Researchers at Johns Hopkins University and the University of Maryland contributed data from two separate studies: the African American Study of Kidney Disease and Hypertension (AASK) and the Chronic Renal Insufficiency Cohort Study (CRIC).

Both studies identified high risk genetic variants in the APOL1 gene that speed up kidney disease progression and substantially increase the risk of developing kidney failure, compared to whites and blacks with low risk variants, with or without diabetes. Approximately 1 in 10 blacks possess the high risk variants, though it is very uncommon in whites.

“Even though our studies found that African Americans with two copies of the high-risk APOL1 variants were at higher risk for kidney disease progression, about 40% of the African Americans from the AASK study who also carried the high-risk variants had not progressed at the time of the study,” said co-lead author W.H. Linda Kao, PhD, MHS, professor of epidemiology and medicine at Johns Hopkins University. “This finding highlights the importance of identifying factors that may modify the effect of the APOL1 risk variants.”

Senior author Lawrence J. Appel, MD, MPH, professor of medicine, epidemiology, and international health at the Johns Hopkins Medical Institutions, noted the importance of the APOL1 gene and its effect on kidney disease progression in blacks.

“Blacks with chronic kidney disease and the high-risk genetic variants were more likely to have kidney disease that progressed, compared to both blacks without the high-risk genotype and whites,” he said.

Appel also stated that African Americans with low-risk variants still had a higher risk of developing kidney failure than whites.

“What we found is pretty remarkable — that variations in a single gene account for much of the racial disparity in kidney disease progression and risk for end-stage kidney disease,” says co-lead author Afshin Parsa, MD, MPH, assistant professor of medicine at the University of Maryland School of Medicine. “If it were possible to reduce the effect of this gene, there could be a very meaningful decrease in progressive kidney and end-stage kidney disease within blacks.” [Read more]



From SevenNews, Australia, by NEDA VANOVAC

Desert communities tackle kidney disease

In a wealthy country like Australia, kidney disease is born out of poverty and dispossession, but the Aboriginal communities in Central Australia hit the hardest are tackling it with a blend of traditional and modern medicine.

In the 1990s, Pintupi communities such as Kintore in the Northern Territory and Kiwirrkurra in Western Australia watched helplessly as many of their senior people had to move up to 700km into town for dialysis, dislocating families and disrupting cultural flow.

"People's kidneys would be failing, they'd know that dialysis was a one-way ticket to Alice Springs and they'd only heard bad stories," says Sarah Brown, manager of Western Desert Dialysis.

"So they'd hide out for as long as possible, get really crook and be evacuated into town, and then it would be a crisis and outcomes would be really bad."

After failing to secure government funding for remote dialysis machines so people could be treated at home, the communities painted big collaborative artworks in 2000 and with the help of Papunya Tula Artists' Centre and Sotheby's auction house auctioned them off at the Art Gallery of NSW.

They raised $1.1 million of independent money "to do something to improve the lives of their mob whose kidneys were buggered", Ms Brown tells AAP.

Western Desert now runs the Purple House in Alice Springs, which has two dialysis machines, and the Purple Truck, which travels Central Australia to bring mobile dialysis to people living in more than 20 remote communities.

There are two machines each now in Kintore, Yuendumu, Hermannsburg, Lajamanu and Warburton, making a total of 14 for the region, and they can treat about 40 patients a day.

This reach is crucial, because Central Australia has the highest per capita rates of kidney disease in the world.

In Australia, it's 15 to 30 times the national average, the result of a combination of factors that stem predominantly from poverty. [Read more]



From NWITimes.com, NorthWest Indiana, by Jim Myers, Guest Commentator

GUEST COMMENTARY: Early detection is important for chronic kidney disease

According to the National Kidney Foundation, 26 million American adults are estimated to have chronic kidney disease, yet many do not know it. Early signs are hard to detect and are easily missed.

Nearly 2.5 million Medicare patients are estimated to have CKD that has not yet become kidney failure. Nearly 600,000 Americans have irreversible kidney disease or end-stage renal disease, which requires dialysis or a transplant to survive.

Nearly 99,000 Americans are on the kidney transplant waiting list. Forty-four percent of ESRD patients had a primary diagnosis of diabetes, the leading cause of ESRD. Twenty-four percent of ESRD patients had a primary diagnosis of hypertension (high blood pressure), the second leading cause of ESRD.

Nearly 3,000 people are added to the kidney waiting list every month. Thirteen people die each day while waiting for a life-saving transplant.

Kidney disease is expensive. The annual cost of the Medicare ESRD program is $28.4 billion. The annual Medicare costs to treat people with CKD is $41 billion, or 22.5 percent of Medicare spending.

Undetected chronic kidney disease can lead to costly and debilitating irreversible kidney failure. However, cost-effective interventions are available if patients are identified in the early stages.

The National Kidney Foundation's Early Evaluation Program reached more than 185,000 individuals at increased risk for developing kidney disease between August 2000 and June 2013. KEEP screenings were offered across the United States to individuals 18 years and older with high blood pressure, diabetes or a family history of kidney failure.

The National Kidney Foundation is calling on health care professionals to screen patients in specific high-risk groups for kidney disease — those age 60 or older and those with high blood pressure or diabetes — by adding a simple urine albumin test for kidney damage to annual physical examinations.

Early detection of kidney disease is critical to stopping the progression of the disease. If you are diagnosed early enough, your kidney disease can be controlled, slowed or delayed with the help of your doctor.

The risks of kidney disease and its complication can be reduced by controlling your blood pressure, maintaining proper weight, quitting smoking, exercising and avoiding excessive pain medication.

I am living proof of this. I lost a cousin, two aunts and an uncle to kidney disease. I lost my dad to polycystic kidney disease. I was diagnosed a mere two months after my father’s death at the age of 25. {Read more]


From JPost.com, Jerusalem, Israel by By JPOST.COM STAFF, GIL HOFFMAN, TOVAH LAZAROFF

Sheba Medical Center director Rotstein: Ex-PM was not on dialysis, but doctors administered antibiotics due to numerous infections.

Former Prime Minister Ariel Sharon is in critical condition, and his life remains in danger due to a deterioration in the function of vital organs, the head of Sheba Medical Center at Tel Hashomer said on Thursday.

Professor Ze'ev Rotstein told reporters on Thursday that Sharon, who was reported to have been suffering from serious kidney failure, was not on dialysis, but that doctors were administering antibiotics due to numerous infections.

"He's getting all the treatment necessary," Rotstein said.

Sharon’s life has been hanging in the balance over the past two days due to what Rotstein said was "a serious deterioration in his health."

Sharon's long-time spokesman, Ra'anan Gissin, said that the former prime minister's kidneys have deteriorated, and "there is no doubt that it is terminal. We can't see any recovery or improvement in his health condition." [Read more]


From ArabNews.com, Jeddah, Saudia Arabia, by NADIM AL-HAMID

Al-Bir Charity sponsors kidney dialysis drive

Kandara Kidney Center (KKC), a subsidiary of the Jeddah Charity Society, conducted 7,925 dialysis operations for 58 patients this year.
Waleed Bahamdan, secretly general of Al-Birr Charity, said the organization provides kidney dialysis operations to underprivileged patients in line with international medical standards.
He pointed out that 62 percent of the patients the organization received are male, while 38 percent are women.
The organization provides other services including awareness programs against the disease, emergency treatment, periodic monitoring of patients’ health condition, and monthly medication.
Bahamdan explained that the society organizes awareness programs as well as dietary consultations for patients to educate them about the healthy lifestyle guidelines to follow.
The official pointed out that they receive donations from various establishments to provide high quality medical care for underprivileged individuals suffering from renal failure.